A new treatment for sexually-transmitted diseases seems to be slowing an STI epidemic — but not everyone can get it ...

Doxycycline postexposure prophylaxis (doxyPEP) initiation is associated with decreases in sexually transmitted infections (STIs).

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

The early rollout of doxyPEP — a dose of the antibiotic doxycycline after sex — has contributed to a decline in sexually ...

The rates of chlamydia and syphilis declined dramatically among individuals living with HIV who were prescribed doxycycline ...

Over the last couple of weeks, there has been a startling uptick in gay men lambasting PrEP on social media, like it’s 2012 ...

Glasgow's drug consumption room is ready to open after years of dialogue and political wrangling. The facility, which is the first of its kind in the UK, will allow people to inject and inhale drugs ...

A new study indicates resistance to shorter and less toxic drug regimens for multidrug-resistant tuberculosis (MDR-TB) is emerging and spreading between patients.

While the use of PrEP has helped drop the rates of HIV infections, instances of syphilis and chlamydia among queer men have ...

Researchers have found in a new new study that Doxycycline post-exposure prophylaxis was effective strategy for reducing incidence of STIs The rates of chlamydia and syphilis plummeted among ...

"These findings suggest that doxyPEP may offer substantial benefits for reducing population-level STI transmission with broader implementation." HealthDay News — Doxycycline postexposure ...

After years of rising rates of syphilis and chlamydia among queer men, it appears a new tool is helping to curb infections. A study says that taking DoxyPEP reduced the incidence of chlamydia and ...